Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Repevax”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT01287949
What this trial is testing

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

Who this might be right for
DiphtheriaTetanusPoliomyelitis+1 more
Sanofi Pasteur, a Sanofi Company 342
Large-scale testing (Phase 3)Study completedNCT00337428
What this trial is testing

Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 843
Post-approval studies (Phase 4)Study completedNCT02526394
What this trial is testing

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

Who this might be right for
PertussisMeningitisPreventive Immunization; Meningitis+1 more
Public Health England 400
Large-scale testing (Phase 3)Study completedNCT01245049
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

Who this might be right for
Acellular PertussisPoliomyelitisTetanus+1 more
GlaxoSmithKline 387
Testing effectiveness (Phase 2)Study completedNCT01323270
What this trial is testing

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

Who this might be right for
Meningococcal VaccinerLP2086Repevax+2 more
Pfizer 753
Large-scale testing (Phase 3)Study completedNCT00400309
What this trial is testing

Safety of REPEVAX® Given One Month After REVAXIS®

Who this might be right for
Healthy Adult
Sanofi Pasteur, a Sanofi Company 500
Large-scale testing (Phase 3)Study completedNCT01249183
What this trial is testing

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi Pasteur, a Sanofi Company 954
Large-scale testing (Phase 3)Study completedNCT01073293
What this trial is testing

V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,054